Atlas Trials

68Ga-grazytracer PET/CT of Tumor Responses to Immunotherapy

Clinical trial NCT05000372 · COMPLETED

Trial details

NCT number
NCT05000372
Sponsor
Peking University Cancer Hospital & Institute
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cancer
Start date
2021-09-22
Primary completion
2024-05-25
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.